GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Net Change in Cash

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Net Change in Cash : €-684.1 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Hangzhou Tigermed Consulting Co's Net Change in Cash for the three months ended in Dec. 2024 was €11.4 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was €-684.1 Mil.

Hangzhou Tigermed Consulting Co Net Change in Cash Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Net Change in Cash Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 995.92 -219.75 -80.66 -49.16 -701.94

Hangzhou Tigermed Consulting Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.14 2.79 -545.34 -152.96 11.36

Hangzhou Tigermed Consulting Co Net Change in Cash Calculation

Hangzhou Tigermed Consulting Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=143.892+-621.625+-223.303+-0.907
=-701.9

Hangzhou Tigermed Consulting Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=67.976+129.069+-187.625+1.94
=11.4

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-684.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Net Change in Cash
Comparable Companies
SZSE:300676 SHSE:603882 SHSE:603127 SHSE:603108 SZSE:300244 SZSE:300406 SZSE:300685 SZSE:300463 SZSE:000710 SZSE:300439 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
03347:Hong Kong 300347:China
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Website
https://www.tigermed.net
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co Headlines

No Headlines